Clinical Trials Browser

Phase 2 × tositumomab I-131 × Plasma cell × Clear all

NCT00135200 2025-04-30

Clinical Trial of Consolidation Treatment With Iodine I 131 Tositumomab for Multiple Myeloma

Phase 2 Completed

16 enrolled 6 charts

Multiple Myeloma